...
首页> 外文期刊>BMC Cancer >Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells
【24h】

Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells

机译:脂肪组织来源的间充质基质细胞介导的人乳腺癌细胞功能改变和化学敏感性增加

获取原文

摘要

Background Mesenchymal stromal cells (MSCs) represent heterogeneous cell population suitable for cell therapies in regenerative medicine. MSCs can also substantially affect tumor biology due to their ability to be recruited to the tumor stroma and interact with malignant cells via direct contacts and paracrine signaling. The aim of our study was to characterize molecular changes dictated by adipose tissue-derived mesenchymal stromal cells (AT-MSCs) and the effects on drug responses in human breast cancer cells SKBR3. Methods The tumor cells were either directly cocultured with AT-MSCs or exposed to MSCs-conditioned medium (MSC-CM). Changes in cell biology were evaluated by kinetic live cell imaging, fluorescent microscopy, scratch wound assay, expression analysis, cytokine secretion profiling, ATP-based viability and apoptosis assays. The efficiency of cytotoxic treatment in the presence of AT-MSCs or MSCs-CM was analyzed. Results The AT-MSCs altered tumor cell morphology, induced epithelial-to-mesenchymal transition, increased mammosphere formation, cell confluence and migration of SKBR3. These features were attributed to molecular changes induced by MSCs-secreted cytokines and chemokines in breast cancer cells. AT-MSCs significantly inhibited the proliferation of SKBR3 cells in direct cocultures which was shown to be dependent on the SDF-1α/CXCR4 signaling axis. MSC-CM-exposed SKBR3 or SKBR3 in direct coculture with AT-MSCs exhibited increased chemosensitivity and induction of apoptosis in response to doxorubicin and 5-fluorouracil. Conclusions Our work further highlights the multi-level nature of tumor-stromal cell interplay and demonstrates the capability of AT-MSCs and MSC-secreted factors to alter the anti-tumor drug responses.
机译:背景间充质基质细胞(MSCs)代表适用于再生医学中细胞疗法的异种细胞群。 MSC由于其被募集到肿瘤基质并通过直接接触和旁分泌信号传导与恶性细胞相互作用的能力,因此也可以大大影响肿瘤生物学。我们研究的目的是表征由脂肪组织衍生的间充质基质细胞(AT-MSC)决定的分子变化以及对人乳腺癌细胞SKBR3药物反应的影响。方法将肿瘤细胞与AT-MSC直接共培养或暴露于MSCs条件培养基(MSC-CM)中。通过动态活细胞成像,荧光显微镜,刮伤试验,表达分析,细胞因子分泌特征分析,基于ATP的生存力和凋亡分析评估了细胞生物学的变化。分析了在AT-MSC或MSCs-CM存在下细胞毒性治疗的效率。结果AT-MSCs改变了肿瘤细胞的形态,诱导了上皮向间充质转化,增加了乳球形成,细胞融合和SKBR3迁移。这些特征归因于乳腺癌细胞中MSCs分泌的细胞因子和趋化因子诱导的分子变化。在直接共培养中,AT-MSC显着抑制SKBR3细胞的增殖,这表明它依赖于SDF-1α/ CXCR4信号转导轴。与AT-MSC直接共培养的MSC-CM暴露的SKBR3或SKBR3表现出增加的化学敏感性和对阿霉素和5-氟尿嘧啶的诱导凋亡诱导。结论我们的工作进一步强调了肿瘤与基质细胞相互作用的多层次性质,并证明了AT-MSC和MSC分泌因子改变抗肿瘤药物反应的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号